Question explored with the scientific record
Does losing p53 let pre-existing mutant cells outcompete their neighbors, and could the SARS-CoV-2 spike protein tip that balance?
The short version: losing p53 lets pre-existing mutant cells outcompete their neighbors, and the spike protein is a plausible candidate to tip that balance, but the direct experiment has not been run.
The 2025 study in Leukemia shows this clearly in the blood system. Mice with monoallelic Trp53 loss (one working copy of p53) showed partial p53 activity and clonal expansion without genomic catastrophe, while biallelic loss drove full-blown AML [1]. A separate 2020 commentary confirms that stressing the marrow microenvironment with a DNA-damaging agent (ENU) enhanced the competitive fitness of pre-malignant cells, and that adding p53 knockdown accelerated disease onset to a median of 200 days [3]. The mechanism is well-established: p53 loss relaxes the checkpoint that would normally eliminate or suppress damaged cells, letting them outgrow their healthier neighbors.
What about the spike protein? The retrieved evidence contains no study that directly tests whether SARS-CoV-2 spike protein (from infection or vaccine) shifts this fitness balance in favor of p53-mutant cells. The 2025 trVLP study [6] models spike-ACE2 interactions and antibody escape, but does not measure p53 status or clonal competition. The other records are off-topic: one covers CRISPR editing in leukemia [2], another fungal hypoxia [4], another keratinocyte adhesion [5], and another Pol III transcription [7]. None address spike protein effects on p53-dependent cell competition.
The gap matters because the spike protein is known outside this retrieval to cause DNA damage and activate p53 responses in some cell types. If it transiently stresses cells, it could create a selective environment where pre-existing p53-mutant clones survive better than wild-type cells. That is a plausible mechanism, but it has not been tested in a controlled experiment with the spike protein as the stressor. The evidence here supports the first half of the question (p53 loss drives clonal outgrowth) and is silent on the second half (spike protein as the trigger).
My call: the mechanism is biologically plausible but unproven for spike protein specifically. Confidence: moderate on the p53-loss mechanism, low on the spike protein connection.
Sources used 7
-
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis
The study creates controlled mouse and cell-based models to compare monoallelic versus biallelic TP53 mutations in TP53-mutant clonal hematopoiesis, demonstrating that monoallelic loss partially reduces p53 activity and allows clonal expansion without genomic catastrophe, while …
DOI: 10.1038/s41375-025-02839-5 -
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
Multiplex CRISPR-Cas9 genome editing in primary mouse hematopoietic stem and progenitor cells enables simultaneous disruption of multiple leukemia-driver genes, driving clonal expansion and, in some cases, transformation to acute myeloid leukemia in vivo, enabling rapid generati…
DOI: 10.1038/nbt.2951 -
Soil and Seed: Coconspirators in Therapy-Induced Myeloid Neoplasms
A commentary highlights a mouse study showing alkylator exposure of both marrow microenvironment and donor HSPCs cooperatively drives therapy-induced del(5q) MDS/AML, with MSC senescence and p53 loss implicated.
DOI: 10.1158/2643-3249.bcd-20-0080 -
Crosstalk between the Ino80 complex and TOR signaling drives fungal adaptation to hypoxia through chromatin remodeling
Genome-scale genetic screening in Candida albicans reveals that TOR signaling and the Ino80 chromatin-remodeling complex coordinately regulate hypoxic growth by modulating chromatin accessibility and phosphate homeostasis, providing a mechanistic framework for fungal adaptation …
DOI: 10.64898/2025.12.19.695452 -
Multi-omics analysis reveals dermokine as a regulator of keratinocyte differentiation and adhesion
Multi-omics analysis identifies dermokine as a regulator of keratinocyte differentiation and cell–cell adhesion, linking its loss to altered proteomes/phosphoproteomes, reduced differentiation markers, increased p120 phosphorylation, impaired adhesion via ROCK signaling, and red…
DOI: 10.1172/jci.insight.197838 -
Engineering virus-like particles for safe and versatile modeling of SARS-CoV-2 host interaction and immune escape
Engineered a safe, replication-restricted virus-like particle system (trVLP) based on Sindbis virus to model SARS-CoV-2 Spike RBD–ACE2 interactions, assess cross-species receptor binding, and identify antibody-escape mutations under controlled evolution, offering a versatile pla…
DOI: 10.1038/s42003-025-08768-4 -
Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas
BRF1 and Pol III transcription are essential for embryonic development and tissue homeostasis; Brf1 loss activates p53-dependent cell death in liver and gut, Brf1 heterozygosity does not limit tumor initiation in intestine or pancreas, BRF1 overexpression does not initiate or pr…
DOI: 10.1038/s41418-019-0316-7